Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13101490 | 0.89 | CTSK (0.42) | CTSKUSP2SMN1; SMN2MAPK1NR1H2 | |
| SCHEMBL1225127 | 0.83 | USP2 (0.58) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL587550 | 0.83 | USP2 (0.58) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL12005408 | 0.83 | USP2 (0.58) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL8286 | 0.83 | USP2 (0.58) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL13101497 | 0.82 | CTSK (0.41) | CTSKUSP2SMN1; SMN2MAPK1NR1H2 | |
| Hydrochloric Acid SCHEMBL4141237 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL14653343 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL132585 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2MAPK1NR1H2HPGD | |
| SCHEMBL2220355 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2MAPK1NR1H2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118272016-B | Aldehyde-free adhesive for artificial boards and preparation method | 大洼县兰田化工有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118420812-B | Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater | 辽宁科技学院 | 2024-10-29 | — | — | CN | claimed |
| CN-118420812-A | Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater | 辽宁科技学院 | 2024-08-02 | — | — | CN | claimed |
| CN-118272016-A | Aldehyde-free adhesive for artificial boards and preparation method | 大洼县兰田化工有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4653419-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE | Otsuka Pharmaceutical Co., Ltd. (JP) | 2025-11-26 | — | — | EP | disclosed |
| CN-119683891-B | Anti-cracking admixture for mass concrete and application thereof | 中交四航局第一工程有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119683891-A | Anti-cracking admixture for mass concrete and application thereof | 中交四航局第一工程有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-118272016-B | Aldehyde-free adhesive for artificial boards and preparation method | 大洼县兰田化工有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118420812-B | Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater | 辽宁科技学院 | 2024-10-29 | — | — | CN | disclosed |
| CN-118420812-A | Preparation method of porous adsorption resin for treating high-salt high-ammonia-nitrogen wastewater and metal wastewater | 辽宁科技学院 | 2024-08-02 | — | — | CN | disclosed |
| WO-2024154763-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE | 大塚製薬株式会社 | 2024-07-25 | — | — | WO | disclosed |
| CN-118272016-A | Aldehyde-free adhesive for artificial boards and preparation method | 大洼县兰田化工有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-8148362-B2 | Compound having heterocyclic ring | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8148362-B2 | Compound having heterocyclic ring | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20100256355-A1 | OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING | Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. | 2010-10-07 | — | — | US | disclosed |
| US-20100256355-A1 | OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING | Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. | 2010-10-07 | — | — | US | disclosed |
| EP-2233484-A2 | Oxazolidinone derivatives having a 7-membered heterocyclic ring | Research Foundation Itsuu Laboratory (JP) | 2010-09-29 | — | — | EP | disclosed |
| EP-2208729-A1 | OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING | Research Foundation Itsuu Laboratory (JP) | 2010-07-21 | — | — | EP | disclosed |
| US-20090299059-A1 | Novel Compound Having Heterocyclic Ring | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090299059-A1 | Novel Compound Having Heterocyclic Ring | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299059-A1 | Novel Compound Having Heterocyclic Ring | NR0B2, NR2C2, NR0B1 | CTSK 4737/4885USP2 3707/4885SMN1; SMN2 2514/4885 |
| US-20100256355-A1 | OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING | NR0B2, NR0B1, NR2C2 | CTSK 4655/4885USP2 3934/4885SMN1; SMN2 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.